Topic Archives: MEI Pharma (MEIP)

MEI Pharma ($MEIP) is a NASDAQ-listed $133M biotech based in San Diego that was spun out by prior owner Australian biotech Novogen ($NVGN), a firm now facing NASDAQ delisting for failing to meet requirements, in 2012. Though I can certainly understand the reluctance of rational biotech investors to avoid any firm even vaguely associated with […]

Comments

  • Avatar

    GOSS, TCRR, KLDO, FIXX, LOGC, DTIL, EDIT, HOOK, AKRO, HARP, BCEL, STOK, PRVL, ALEC, MEIP, BDTX...

  • Avatar

    MEI Pharma (MEIP). It was not hard for me to figure out with the clues he gave, most notably, MEI received FDA fast trac...

  • Avatar

    The email blast he's been sending out this month for a cancer company treating lymphoma that "could save your life" is M...

  • Avatar

    I figured out Jovine's April takeover candidate. It's MEI Pharma (MEIP). This company is developing a drug for lymphoma....

  • Avatar

    I got his email yesterday about the "#1 takeover target for April." He gave some clues suchs as this company is going to...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info